Shreeoswal Seeds & Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 8:39 pm

Market Cap	130 Cr.
Current Price	14.2
High / Low	40.8/11.6
Stock P/E
Book Value	4.13
Dividend Yield	0.00 %
ROCE	0.62 %
ROE	9.84 %
Face Value	2.00
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Shreeoswal Seeds & Chemicals Ltd

Competitors of Shreeoswal Seeds & Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Genomic Valley Biotech Ltd	13.9 Cr.	45.6	108/33.4	38.7	12.7	0.00 %	11.8 %	9.68 %	10.0
Genesis IBRC India Ltd	25.0 Cr.	19.2	19.2/13.7	7.15	6.56	0.00 %	51.6 %	51.6 %	10.0
Shreeoswal Seeds & Chemicals Ltd	130 Cr.	14.2	40.8/11.6		4.13	0.00 %	0.62 %	9.84 %	2.00
Nath Bio-Genes (India) Ltd	357 Cr.	188	264/138	8.58	341	1.06 %	7.20 %	6.61 %	10.0
Continental Seeds and Chemicals Ltd	26.5 Cr.	24.1	70.2/22.1		21.8	0.00 %	10.0 %	18.0 %	10.0
Industry Average	243.50 Cr	58.22		18.14	77.24	0.21%	16.24%	19.15%	8.40

All Competitor Stocks of Shreeoswal Seeds & Chemicals Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	23.33	126.74	32.69	86.62	26.27	83.32	65.55	76.74	43.42	76.95	67.69	75.42
Expenses	21.94	118.85	32.82	82.92	25.82	78.90	63.15	77.92	48.05	78.98	66.16	67.30
Operating Profit	1.39	7.89	-0.13	3.70	0.45	4.42	2.40	-1.18	-4.63	-2.03	1.53	8.12
OPM %	5.96%	6.23%	-0.40%	4.27%	1.71%	5.30%	3.66%	-1.54%	-10.66%	-2.64%	2.26%	10.77%
Other Income	0.07	0.02	0.02	0.02	0.07	0.00	0.01	0.00	0.09	0.01	0.00	0.05
Interest	1.04	0.82	0.84	1.51	0.53	1.49	1.38	1.54	1.57	1.45	0.95	0.75
Depreciation	0.24	0.10	0.10	0.11	0.12	0.12	0.14	0.17	0.08	0.13	0.13	0.12
Profit before tax	0.18	6.99	-1.05	2.10	-0.13	2.81	0.89	-2.89	-6.19	-3.60	0.45	7.30
Tax %	144.44%	20.03%	23.81%	20.95%	76.92%	28.11%	28.09%	14.88%	-43.30%	-24.44%	31.11%	26.44%
Net Profit	-0.07	5.58	-1.30	1.66	-0.23	2.03	0.64	-3.32	-3.51	-2.72	0.32	5.37
EPS in Rs	-0.01	0.61	-0.14	0.18	-0.03	0.22	0.07	-0.36	-0.38	-0.30	0.03	0.59

Last Updated: February 28, 2025, 5:10 pm

Below is a detailed analysis of the quarterly data for Shreeoswal Seeds & Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 75.42 Cr.. The value appears strong and on an upward trend. It has increased from 67.69 Cr. (Sep 2024) to 75.42 Cr., marking an increase of 7.73 Cr..
For Expenses, as of Dec 2024, the value is 67.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.16 Cr. (Sep 2024) to 67.30 Cr., marking an increase of 1.14 Cr..
For Operating Profit, as of Dec 2024, the value is 8.12 Cr.. The value appears strong and on an upward trend. It has increased from 1.53 Cr. (Sep 2024) to 8.12 Cr., marking an increase of 6.59 Cr..
For OPM %, as of Dec 2024, the value is 10.77%. The value appears strong and on an upward trend. It has increased from 2.26% (Sep 2024) to 10.77%, marking an increase of 8.51%.
For Other Income, as of Dec 2024, the value is 0.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 0.05 Cr., marking an increase of 0.05 Cr..
For Interest, as of Dec 2024, the value is 0.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.95 Cr. (Sep 2024) to 0.75 Cr., marking a decrease of 0.20 Cr..
For Depreciation, as of Dec 2024, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.13 Cr. (Sep 2024) to 0.12 Cr., marking a decrease of 0.01 Cr..
For Profit before tax, as of Dec 2024, the value is 7.30 Cr.. The value appears strong and on an upward trend. It has increased from 0.45 Cr. (Sep 2024) to 7.30 Cr., marking an increase of 6.85 Cr..
For Tax %, as of Dec 2024, the value is 26.44%. The value appears to be improving (decreasing) as expected. It has decreased from 31.11% (Sep 2024) to 26.44%, marking a decrease of 4.67%.
For Net Profit, as of Dec 2024, the value is 5.37 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Sep 2024) to 5.37 Cr., marking an increase of 5.05 Cr..
For EPS in Rs, as of Dec 2024, the value is 0.59. The value appears strong and on an upward trend. It has increased from 0.03 (Sep 2024) to 0.59, marking an increase of 0.56.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:52 pm

Metric	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	18	126	117	161	241	272	269	263
Expenses	16	120	110	154	230	260	268	260
Operating Profit	2	6	7	8	10	12	1	3
OPM %	10%	5%	6%	5%	4%	4%	0%	1%
Other Income	0	0	0	0	0	0	0	0
Interest	1	2	2	2	3	4	6	5
Depreciation	0	0	0	0	0	0	1	0
Profit before tax	1	4	4	5	8	8	-5	-2
Tax %	20%	26%	28%	28%	28%	28%	-23%
Net Profit	1	3	3	4	5	6	-4	-1
EPS in Rs	0.18	0.31	0.33	0.40	0.59	0.62	-0.45	-0.06
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	200.00%	0.00%	33.33%	25.00%	20.00%	-166.67%
Change in YoY Net Profit Growth (%)	0.00%	-200.00%	33.33%	-8.33%	-5.00%	-186.67%

Shreeoswal Seeds & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	16%
3 Years:	1%
TTM:	-9%

Compounded Profit Growth
10 Years:	%
5 Years:	2%
3 Years:	-13%
TTM:	185%

Stock Price CAGR
10 Years:	%
5 Years:	24%
3 Years:	-6%
1 Year:	-45%

Return on Equity
10 Years:	%
5 Years:	7%
3 Years:	4%
Last Year:	8%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:46 pm

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	11	15	15	15	15	15	18	18
Reserves	1	11	14	18	23	29	22	20
Borrowings	25	24	30	43	42	41	64	34
Other Liabilities	15	11	7	16	40	43	20	31
Total Liabilities	52	61	66	93	120	128	124	103
Fixed Assets	2	2	4	4	4	4	7	7
CWIP	0	0	0	0	0	1	2	2
Investments	0	0	0	0	0	0	0	0
Other Assets	50	59	63	89	115	122	115	94
Total Assets	52	61	66	93	120	128	124	103

Below is a detailed analysis of the balance sheet data for Shreeoswal Seeds & Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
For Reserves, as of Sep 2024, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2024) to 20.00 Cr., marking a decrease of 2.00 Cr..
For Borrowings, as of Sep 2024, the value is 34.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 64.00 Cr. (Mar 2024) to 34.00 Cr., marking a decrease of 30.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 11.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 103.00 Cr.. The value appears to be improving (decreasing). It has decreased from 124.00 Cr. (Mar 2024) to 103.00 Cr., marking a decrease of 21.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
For CWIP, as of Sep 2024, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Mar 2024) to 94.00 Cr., marking a decrease of 21.00 Cr..
For Total Assets, as of Sep 2024, the value is 103.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Mar 2024) to 103.00 Cr., marking a decrease of 21.00 Cr..

However, the Borrowings (34.00 Cr.) are higher than the Reserves (₹20.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-10	-10	-4	-11	5	10	-15
Cash from Investing Activity +	-0	1	-3	-0	-1	-2	-4
Cash from Financing Activity +	10	13	4	10	-4	-4	17
Net Cash Flow	0	3	-3	-1	1	3	-2

Free Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-23.00	-18.00	-23.00	-35.00	-32.00	-29.00	-63.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	227	32	39	14	29	11	24
Inventory Days	790	134	147	190	144		1,540
Days Payable	334	28	3	4	5		53
Cash Conversion Cycle	683	137	182	201	168	11	1,511
Working Capital Days	676	128	168	160	113	100	122
ROCE %		14%	12%	11%	13%	14%	1%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	69.98%	69.98%	69.98%	69.98%	69.98%	69.98%	69.98%	69.98%	69.98%	69.66%	66.63%	66.63%
FIIs	0.00%	0.00%	0.00%	0.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%
DIIs	0.13%	0.13%	0.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	29.89%	29.89%	29.88%	29.89%	30.02%	30.03%	30.02%	30.02%	30.02%	30.34%	33.37%	33.37%
No. of Shareholders	164	144	142	181	611	1,144	2,713	4,089	9,198	10,792	29,272	27,610

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	10.00	10.00	10.00
Basic EPS (Rs.)	-0.45	0.62	3.57	2.39	2.00
Diluted EPS (Rs.)	-0.45	0.62	3.57	2.39	2.00
Cash EPS (Rs.)	-0.39	0.80	3.82	2.59	2.20
Book Value[Excl.RevalReserv]/Share (Rs.)	4.40	5.82	25.38	21.81	19.42
Book Value[Incl.RevalReserv]/Share (Rs.)	4.40	5.82	25.38	21.81	19.42
Revenue From Operations / Share (Rs.)	29.41	35.73	157.77	105.75	76.53
PBDIT / Share (Rs.)	0.12	1.58	6.94	5.11	4.66
PBIT / Share (Rs.)	0.06	1.52	6.68	4.92	4.46
PBT / Share (Rs.)	-0.58	1.04	4.97	3.32	2.78
Net Profit / Share (Rs.)	-0.45	0.74	3.56	2.39	2.00
NP After MI And SOA / Share (Rs.)	-0.45	0.74	3.56	2.39	2.00
PBDIT Margin (%)	0.41	4.41	4.39	4.83	6.08
PBIT Margin (%)	0.22	4.26	4.23	4.64	5.82
PBT Margin (%)	-1.99	2.89	3.14	3.13	3.62
Net Profit Margin (%)	-1.54	2.09	2.25	2.26	2.61
NP After MI And SOA Margin (%)	-1.54	2.09	2.25	2.26	2.61
Return on Networth / Equity (%)	-10.34	12.86	14.04	10.97	10.28
Return on Capital Employeed (%)	1.44	24.85	23.49	19.23	22.58
Return On Assets (%)	-3.35	4.45	4.53	3.93	4.59
Long Term Debt / Equity (X)	0.00	0.03	0.11	0.16	0.01
Total Debt / Equity (X)	1.59	0.92	1.07	1.30	1.02
Asset Turnover Ratio (%)	2.13	2.20	1.08	1.09	1.17
Current Ratio (X)	1.35	1.49	1.50	1.63	1.69
Quick Ratio (X)	0.35	0.23	0.33	0.24	0.55
Inventory Turnover Ratio (X)	2.71	2.99	1.45	2.13	2.07
Interest Coverage Ratio (X)	0.18	3.25	4.05	3.20	2.92
Interest Coverage Ratio (Post Tax) (X)	0.30	2.54	3.08	2.50	2.30
Enterprise Value (Cr.)	327.05	2511.48	126.80	89.37	63.77
EV / Net Operating Revenue (X)	1.22	9.22	0.52	0.55	0.54
EV / EBITDA (X)	293.97	208.68	11.99	11.46	8.98
MarketCap / Net Operating Revenue (X)	0.98	9.09	0.36	0.29	0.30
Price / BV (X)	6.62	55.80	2.25	1.41	1.18
Price / Net Operating Revenue (X)	0.98	9.09	0.36	0.29	0.30
EarningsYield	-0.01	0.00	0.06	0.07	0.08

After reviewing the key financial ratios for Shreeoswal Seeds & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is -0.45. This value is below the healthy minimum of 5. It has decreased from 0.62 (Mar 23) to -0.45, marking a decrease of 1.07.
For Diluted EPS (Rs.), as of Mar 24, the value is -0.45. This value is below the healthy minimum of 5. It has decreased from 0.62 (Mar 23) to -0.45, marking a decrease of 1.07.
For Cash EPS (Rs.), as of Mar 24, the value is -0.39. This value is below the healthy minimum of 3. It has decreased from 0.80 (Mar 23) to -0.39, marking a decrease of 1.19.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 4.40. It has decreased from 5.82 (Mar 23) to 4.40, marking a decrease of 1.42.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 4.40. It has decreased from 5.82 (Mar 23) to 4.40, marking a decrease of 1.42.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 29.41. It has decreased from 35.73 (Mar 23) to 29.41, marking a decrease of 6.32.
For PBDIT / Share (Rs.), as of Mar 24, the value is 0.12. This value is below the healthy minimum of 2. It has decreased from 1.58 (Mar 23) to 0.12, marking a decrease of 1.46.
For PBIT / Share (Rs.), as of Mar 24, the value is 0.06. This value is within the healthy range. It has decreased from 1.52 (Mar 23) to 0.06, marking a decrease of 1.46.
For PBT / Share (Rs.), as of Mar 24, the value is -0.58. This value is below the healthy minimum of 0. It has decreased from 1.04 (Mar 23) to -0.58, marking a decrease of 1.62.
For Net Profit / Share (Rs.), as of Mar 24, the value is -0.45. This value is below the healthy minimum of 2. It has decreased from 0.74 (Mar 23) to -0.45, marking a decrease of 1.19.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -0.45. This value is below the healthy minimum of 2. It has decreased from 0.74 (Mar 23) to -0.45, marking a decrease of 1.19.
For PBDIT Margin (%), as of Mar 24, the value is 0.41. This value is below the healthy minimum of 10. It has decreased from 4.41 (Mar 23) to 0.41, marking a decrease of 4.00.
For PBIT Margin (%), as of Mar 24, the value is 0.22. This value is below the healthy minimum of 10. It has decreased from 4.26 (Mar 23) to 0.22, marking a decrease of 4.04.
For PBT Margin (%), as of Mar 24, the value is -1.99. This value is below the healthy minimum of 10. It has decreased from 2.89 (Mar 23) to -1.99, marking a decrease of 4.88.
For Net Profit Margin (%), as of Mar 24, the value is -1.54. This value is below the healthy minimum of 5. It has decreased from 2.09 (Mar 23) to -1.54, marking a decrease of 3.63.
For NP After MI And SOA Margin (%), as of Mar 24, the value is -1.54. This value is below the healthy minimum of 8. It has decreased from 2.09 (Mar 23) to -1.54, marking a decrease of 3.63.
For Return on Networth / Equity (%), as of Mar 24, the value is -10.34. This value is below the healthy minimum of 15. It has decreased from 12.86 (Mar 23) to -10.34, marking a decrease of 23.20.
For Return on Capital Employeed (%), as of Mar 24, the value is 1.44. This value is below the healthy minimum of 10. It has decreased from 24.85 (Mar 23) to 1.44, marking a decrease of 23.41.
For Return On Assets (%), as of Mar 24, the value is -3.35. This value is below the healthy minimum of 5. It has decreased from 4.45 (Mar 23) to -3.35, marking a decrease of 7.80.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 23) to 0.00, marking a decrease of 0.03.
For Total Debt / Equity (X), as of Mar 24, the value is 1.59. This value exceeds the healthy maximum of 1. It has increased from 0.92 (Mar 23) to 1.59, marking an increase of 0.67.
For Asset Turnover Ratio (%), as of Mar 24, the value is 2.13. It has decreased from 2.20 (Mar 23) to 2.13, marking a decrease of 0.07.
For Current Ratio (X), as of Mar 24, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.49 (Mar 23) to 1.35, marking a decrease of 0.14.
For Quick Ratio (X), as of Mar 24, the value is 0.35. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 23) to 0.35, marking an increase of 0.12.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.71. This value is below the healthy minimum of 4. It has decreased from 2.99 (Mar 23) to 2.71, marking a decrease of 0.28.
For Interest Coverage Ratio (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 3. It has decreased from 3.25 (Mar 23) to 0.18, marking a decrease of 3.07.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 3. It has decreased from 2.54 (Mar 23) to 0.30, marking a decrease of 2.24.
For Enterprise Value (Cr.), as of Mar 24, the value is 327.05. It has decreased from 2,511.48 (Mar 23) to 327.05, marking a decrease of 2,184.43.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.22. This value is within the healthy range. It has decreased from 9.22 (Mar 23) to 1.22, marking a decrease of 8.00.
For EV / EBITDA (X), as of Mar 24, the value is 293.97. This value exceeds the healthy maximum of 15. It has increased from 208.68 (Mar 23) to 293.97, marking an increase of 85.29.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 9.09 (Mar 23) to 0.98, marking a decrease of 8.11.
For Price / BV (X), as of Mar 24, the value is 6.62. This value exceeds the healthy maximum of 3. It has decreased from 55.80 (Mar 23) to 6.62, marking a decrease of 49.18.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 9.09 (Mar 23) to 0.98, marking a decrease of 8.11.
For EarningsYield, as of Mar 24, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.00 (Mar 23) to -0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Shreeoswal Seeds & Chemicals Ltd as of June 1, 2025 is: 4.97

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, Shreeoswal Seeds & Chemicals Ltd is Overvalued by 65.00% compared to the current share price 14.20

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Shreeoswal Seeds & Chemicals Ltd as of June 1, 2025 is: 4.61

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, Shreeoswal Seeds & Chemicals Ltd is Overvalued by 67.54% compared to the current share price 14.20

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -7.29%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (183.38 cr) and profit (2.88 cr) over the years.	The stock has a low average ROCE of 9.29%, which may not be favorable. The stock has a high average Working Capital Days of 209.57, which may not be favorable. The stock has a high average Cash Conversion Cycle of 197.57, which may not be favorable. The company has higher borrowings (37.88) compared to reserves (17.25), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Shreeoswal Seeds & Chemicals Ltd:
1. Net Profit Margin: -1.54%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 1.44% (Industry Average ROCE: 16.24%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: -10.34% (Industry Average ROE: 19.15%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 0.3
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.35
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 18.14)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 1.59
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Shreeoswal Seeds and Chemicals Ltd. is a Public Limited Listed company incorporated on 29/07/2002 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L01111MP2017PLC044596 and registration number is 044596. Currently Company is involved in the business activities of Preparation of crops for primary markets, i.e. cleaning, trimming, grading, disinfecting. Company's Total Operating Revenue is Rs. 100.61 Cr. and Equity Capital is Rs. 18.29 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Seeds/Tissue Culture/Bio Technology	Oswal House, Neemuch Madhya Pradesh 458441	oswalgroups2002@gmail.com http://www.oswalseeds.com

Management
Name	Position Held
Mr. Sanjay Kumar Baigani	Chairman & Managing Director
Mr. Anil Kumar Nahata	WholeTime Director & CEO
Mrs. Kiran Devi Begani	Non Exe.Non Ind.Director
Mrs. Padma Nahta	Non Exe.Non Ind.Director
Mr. Gopal Lal Agarwal	Ind. Non-Executive Director
Mr. Yash Wardhan Jain	Ind. Non-Executive Director
Mr. Sanjay Chordiya	Ind. Non-Executive Director
Mr. Umesh Kumar Sharma	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Shreeoswal Seeds & Chemicals Ltd?

Shreeoswal Seeds & Chemicals Ltd's intrinsic value (as of 01 June 2025) is ₹4.97 — 65.00% lower the current market price of 14.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 130 Cr. market cap, FY2025-2026 high/low of ₹40.8/11.6, reserves of 20 Cr, and liabilities of 103 Cr.

What is the Market Cap of Shreeoswal Seeds & Chemicals Ltd?

The Market Cap of Shreeoswal Seeds & Chemicals Ltd is 130 Cr..

What is the current Stock Price of Shreeoswal Seeds & Chemicals Ltd as on 01 June 2025?

The current stock price of Shreeoswal Seeds & Chemicals Ltd as on 01 June 2025 is 14.2.

What is the High / Low of Shreeoswal Seeds & Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Shreeoswal Seeds & Chemicals Ltd stocks is ₹40.8/11.6.

What is the Stock P/E of Shreeoswal Seeds & Chemicals Ltd?

The Stock P/E of Shreeoswal Seeds & Chemicals Ltd is .

What is the Book Value of Shreeoswal Seeds & Chemicals Ltd?

The Book Value of Shreeoswal Seeds & Chemicals Ltd is 4.13.

What is the Dividend Yield of Shreeoswal Seeds & Chemicals Ltd?

The Dividend Yield of Shreeoswal Seeds & Chemicals Ltd is 0.00 %.

What is the ROCE of Shreeoswal Seeds & Chemicals Ltd?

The ROCE of Shreeoswal Seeds & Chemicals Ltd is 0.62 %.

What is the ROE of Shreeoswal Seeds & Chemicals Ltd?

The ROE of Shreeoswal Seeds & Chemicals Ltd is 9.84 %.

What is the Face Value of Shreeoswal Seeds & Chemicals Ltd?

The Face Value of Shreeoswal Seeds & Chemicals Ltd is 2.00.